Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001836067-25-000004
Filing Date
2025-09-12
Accepted
2025-09-12 16:07:11
Documents
1
Period of Report
2025-09-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1757707628.html 4  
1 FORM 4 wk-form4_1757707628.xml 4 4822
  Complete submission text file 0001836067-25-000004.txt   6418
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001356576 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SUPERNUS PHARMACEUTICALS, INC. 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 3018382500
Rubin Jonathan (Reporting) CIK: 0001836067 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35518 | Film No.: 251311544